Jeffrey How

10PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 25, 2026
Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint Inhibitors.

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Nov 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

Mohamed A Gouda, Bettzy Stephen, Yanyan Tian

|Oct 12, 2024
TERT promoter mutations and survival outcomes in adult-type granulosa cell tumors.

Allison L Brodsky, Alejandra Flores Legarreta, Bryan M Fellman

|Aug 28, 2024
Translating biological insights into improved management of endometrial cancer.

Jeffrey A How, Amir A Jazaeri, Shannon N Westin

|Aug 12, 2022
Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials.

Jeffrey A How, Amir A Jazaeri, Siqing Fu

Pageof 2

Frequent Collaborators

2 joint publications

Aung Naing

2 joint publications

Amir A Jazaeri

2 joint publications

Bettzy Stephen

2 joint publications

Shannon N Westin